A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder

Psychoneuroendocrinology

Volumn 28, Issue SUPPL. 3, 2003, Pages 39-53

  Rapkin, Andrea ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drospirenone; Hormones; Oral contraceptives; Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BUSPIRONE; CALCIUM; CARBOHYDRATE; CITALOPRAM; CLOMIPRAMINE; DANAZOL; DESOGESTREL; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; FLUOXETINE; GONADORELIN AGONIST; LEVONORGESTREL; MAGNESIUM; NANDROLONE DERIVATIVE; NORGESTIMATE; PAROXETINE; PROGESTERONE; PROGESTERONE DERIVATIVE; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; VENLAFAXINE; ANDROSTANE DERIVATIVE; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; EXERCISE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MINERAL INTAKE; NONHUMAN; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RELAXATION TRAINING; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION; FEMALE; PSYCHOLOGICAL ASPECT;

ANDROSTENES; CONTRACEPTIVES, ORAL; FEMALE; GONADAL STEROID HORMONES; HUMANS; PREMENSTRUAL SYNDROME;

EID: 0642281481     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00096-9     Document Type: Article

References (66)

1. ACOG (American College of Obstetricians and Gynecologists), 2000. Premenstrual Syndrome. ACOG Practice Bulletin No. 15, April.
2. APA (American Psychiatric Association), 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. (DSM-IV). American Psychiatric Association, Washington, DC, pp. 715-718.
3. Ashby, C.R., Carr, L.A., Cook, C.L., Steptoe, M.M., Franks, D.D., 1988. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual synrome. Biol. Psychiatry 24, 225-233.
4. Aslaksen, K., Falk, V., 1991. Spironolactone in the treatment of premenstrual tension: A double-blind study of spironolactone versus bendrflumehtiazide and placebo. Curr. Ther. Res. 49, 120-130.
5. Bäckström, T., Hansson-Malmström, Y., Lindhe, B.Å, Cavalli-Björkman, B., Nordenström, S., 1992. Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations. Contraception 46, 253-268.
6. Biegon, A., McEwen, B.S., 1982. Modulation by estradiol of serotonin receptors in brain. J. Neurosci. 2, 199-205.
7. Blake, F., Salkovskis, P., Gath, D., Day, A., Garrod, A., 1998. Cognitive therapy for premenstrual syndrome: A controlled trial. J. Psychosom. Res. 45, 307-318.
8. Brown, C.S., Ling, F.W., Andersen, R.N., Farmer, R.G., Arheart, K.L., 1994. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet. Gynecol. 84, 779-786.
9. Casper, R.F., Hearn, M.T., 1990. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am. J. Obstet. Gynecol. 162, 105-109.
10. Christensen, A.P., Oei, T.P., 1995. The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. J. Affect. Disor. 33, 57-63.
11. Di Carlo, C., Palomba, S., Tommaselli, G.A., Guida, M., Di Spiezio Sardo, A., Nappi, C., 2001. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil. Steril. 75 (2), 380-384.
12. Dimmock, P.W., Wyatt, K.M., Jones, P.W., O'Brien, P.M.S., 2000. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review. Lancet 356 (9236), 1131-1136.
13. Dougherty, D.M., Bjork, J.M., Moeller, F.G., Swann, A.C., 1997. The influence of menstrual-cycle phase on the relationship between testosterone and aggression. Physiol. Behav. 62, 431-435.
14. Eriksson, E., Hedberg, M.A., Andersch, B., Sundblad, C., 1995. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12, 167-176.
15. Eriksson, E., Sundblad, C., Lisjo, P., Modigh, K., Andersch, B., 1992. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 17, 195-204.
16. Facchinetti, F., Borella, P., Sances, G., Fioroni, L., Nappi, R.E., Genazzani, A.R., 1991. Oral magnesium successfully relieves premenstrual mood changes. Obstet. Gynecol. 78, 177-181.
17. Freeman, E.W., Rickels, K., Sondheimer, S.J., Wittmaack, F.M., 1996. Sertraline versus desipramine in the treatment of premenstrual syndrome: An open-label trial. J. Clin. Psychiatry 57, 7-11.
18. Freeman, E.W., Rickels, K., Sondheimer, S.J., Polansky, M., 1995. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 274, 51-57.
19. Freeman, E.W., Sondheimer, S.J., Rickels, K., Albert, J., 1993. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: A pilot study. J. Clin. Psychiatry 54, 192-195.
20. Freeman, E.W., Kroll, R., Rapkin, A., for the PMS/PMDD Research Group 2001a. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J. Womens Health Gend. Based Med. 10, 561-569.
21. Freeman, E.W., Rickels, K., Yonkers, K.A., Kunz, N.R., McPherson, M., Upton, G.V., 2001b. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet. Gynecol. 98 (5), 737-744.
22. Fuhrmann, U., Krattenmacher, R., Slater, E.P., Frizemeier, K.H., 1996. The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential. Contraception 54, 243-251.
23. Goodale, I.L., Domar, A.D., Benson, H., 1990. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet. Gynecol. 75, 649-655.
24. Graham, C.A., Sherwin, B.B., 1992. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J. Psychosom. Res. 36, 257-266.
25. Halbreich, U., Rojansky, N., Palter, S., 1991. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil. Steril. 56, 1066-1069.
26. Halbreich, U., Smoller, J.W., 1997. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J. Clin. Psychiatry 58, 399-402.
27. Harrison, W.M., Endicott, J., Nee, J., 1990. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch. Gen. Psychiatry 47, 270-275.
28. Jermain, D.M., Preece, C.K., Sykes, R.L., Kuehl, T.J., Sulak, P.J., 1999. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study. Arch. Fam. Med. 8, 328-332.
29. Kirkby, R.J., 1994. Changes in premenstrual symptoms and irrational thinking following cognitive-behavioral coping skills training. J. Consult. Clin. Psychol. 62, 1026-1032.
30. London, R.S., Murphy, L., Kitlowski, K.E., Reynolds, M.A., 1987. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J. Reprod. Med. 32, 400-404.
31. Morse, C.A., Dennerstein, L., Farrell, E., Varnavides, K., 1991. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome. J. Behav. Med. 14, 469-489.
32. Mortola, J.F., 1993. Applications of gonadotropin-releasing hormone analogues in the treatment of pre-menstrual syndrome. Clin. Obstet. Gynecol. 36, 753-763.
33. Mortola, J.F., Girton, L., Beck, L., Yen, S.S., 1990. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences. Obstet. Gynecol. 76, 302-307.
34. Mortola, J.F., Girton, L., Fischer, U., 1991. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J. Clin. Endocrinol. Metab. 72, 252A-252F.
35. Muse, K.N., Cetel, N.S., Futterman, L.A., Yen, S.C., 1984. The premenstrual syndrome. Effects of "medical ovariectomy". N. Engl. J. Med. 311, 1345-1349.
36. O'Brien, P.M.S., Craven, D., Selby, C., Symonds, E.M., 1979. Treatment of premenstrual syndrome by spironolactone. Br. J. Obstet. Gynaecol. 86, 141-147.
37. O'Brien, P.M.S., Abukhalil, I.E.H., 1999. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am. J. Obstet. Gynecol. 180, 18-23.
38. Parsey, K.S., Pong, A., 2000. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 61, 105-111.
39. Pearlstein, T.B., Halbreich, U., Batzar, E.D., Brown, C.S., Endicott, J., Frank, E., Greeman, E.W., Harrison, W.M., Haskett, R.F., Stout, A.L., Yonkers, K.A., 2000. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with Sertraline or placebo. J. Clin. Psychiatry 61, 101-109.
40. Pearlstein, T.B., Stone, A.B., 1994. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J. Clin. Psychiatry 55, 332-335.
41. Pearlstein, T.B., Stone, A.B., Lund, S.A., Scheft, H., Zlotnick, C., Brown, W.A., 1997. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J. Clin. Psychopharmacol. 17, 261-266.
42. Prior, J.C., Vigna, Y., Sciarretta, D., Alojado, N., Schulzer, M., 1987. Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil. Steril. 47, 402-408.
43. Rapkin, A.J., 1992. The role of serotonin in premenstrual syndrome. Clin. Obstet. Gynecol. 35, 629-636.
44. Rapkin, A.J., Chang, L.C., Reading, A.E., 1988. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol. Rep. 62, 55-60.
45. Rapkin, A.J., Edelmuth, E., Chang, L.C., Reading, A.E., McGuire, M.T., Su, T.P., 1987a. Whole-blood serotonin in premenstrual syndrome. Obstet. Gynecol. 70, 533-537.
46. Rapkin, A.J., Chang, L.C., Reading, A.E., 1987b. Premenstrual syndrome: a double blind placebo controlled study of treatment with progesterone vaginal suppositories. J. Obstet. Gynecol. 7, 217-220.
47. Rapkin, A.J., Morgan, M., Goldman, L., Brann, D.W., Simone, D., Mehesh, V.B., 1997. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Gynecol. 90, 709-714.
48. Rickels, K., Freeman, E., Sondheimer, S., 1989. Buspirone in treatment of premenstrual syndrome [letter]. Lancet 1, 777.
49. Rubinow, D.R., Hoban, M.C., Grover, G.N., et al. 1988. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am. J. Obstet. Gynecol. 158, 5-11.
50. Sarno, A.P. Jr, Miller, E.J. Jr, Lundblad, E.G., 1987. Premenstrual syndrome: Beneficial effects of periodic, low-dose danazol. Obstet. Gynecol. 70, 33-36.
51. Sayegh, R., Schiff, I., Wurtman, J., Spiers, P., McDermott, J., Wurtman, R., 1995. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet. Gynecol. 86, 520-528.
52. Schmidt, P.J., Nieman, L.K., Danaceau, M.A., Adams, L.F., Rubinow, D.R., 1998. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 338, 209-216.
53. Steege, J.F., Blumenthal, J.A., 1993. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: A preliminary study. J. Psychosom. Res. 37, 127-133.
54. Steinberg, S., Annable, L., Young, S.N., Liyanage, N., 1999. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol. Psychiatry 45, 313-320.
55. Steiner, M., Korzekwa, M., Lamont, J., Wilkins, A., 1997. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol. Bull. 33, 771-774.
56. Steiner, M., Steinberg, S., Stewart, D., et al. 1995. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N. Engl. J. Med. 332, 1529-1534.
57. Sulak, P.J., Scow, R.D., Preece, C., Riggs, M.W., Kuehl, T.J., 2000. Hormone withdrawal symptoms in oral contraceptive users, continuous use. Obstet. Gynecol. 95, 261-266.
58. Sundblad, C., Hedberg, M.A., Eriksson, E., 1993. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 9, 133-145.
59. Sundblad, C., Modigh, K., Andersch, B., Eriksson, E., 1992. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta. Psychiatr. Scand. 85, 39-47.
60. Thys-Jacobs, S., Starkey, P., Bernstein, D., Tian, J., 1998. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am. J. Obstet. Gynecol. 179, 444-452.
61. Thys-Jacobs, S., Ceccarelli, S., Bierman, A., et al. 1989. Calcium supplementation in premenstrual syndrome: A randomized crossover trial. J. Gen. Intern. Med. 4, 183-189.
62. Watson, N.R., Studd, J.W.W., Savvas, M., Garnett, T., Baber, R.J., 1989. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 2, 730-732.
63. Wikander, I., Sundblad, C., Andersch, B., et al. 1998. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J. Clin Psychopharmacol. 18, 390-398.
64. Wyatt, K.M., Dimmock, P.W., Jones, P.W., Shaughn O'Brien, P.M., 1999. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 318, 1375-1381.
65. Yonkers, K.A., Halbreich, U., Freeman, E., et al. 1997. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA 278, 983-988.
66. Young, S.A., Hurt, P.H., Benedek, D.M., Howard, R.S., 1998. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial. J. Clin. Psychiatry 59, 76-80.